In addition, we demonstrated that αHER2/Lipo-DiR and αHER2/SPIO enhances accumulation in MCF7-HER2 tumors (HER2++) by 175% and 186% in mice compared with MCF7/neo1 tumor (HER2+/−). This evidence concerns the gene ERBB2 and neoplasm.